The 2025-2026 SARS-CoV-2 vaccines provided protection against ED/UC visits and hospitalizations among immunocompetent adults.

Infections, not eosinophilic inflammation, are the primary cause of asthma exacerbations in patients receiving benralizumab.

Studies suggesting a link between COVID-19 vaccination and improved outcomes with ICIs may be driven by pandemic-era confounding and selection bias.

A meta-analysis indicates HD-IIV is superior to SD-IIV for reducing hospitalizations in adults aged 65 years and older.

For adults with long COVID-related cognitive impairment, individualized, goal-oriented cognitive rehabilitation leads to sustained improvements in goal attainment.

Many young adults lack a primary care provider and utilize urgent care clinics for nonemergency issues instead of scheduling routine checkups.

Implementation of a rapid molecular pneumonia panel is associated with earlier antimicrobial optimization among critically ill patients with pneumonia.

Provisional CDC data indicate that the overall US death rate decreased across all age groups, reaching the lowest recorded level.

A 24-week treatment with bofanglutide for patients with type 2 diabetes showed meaningful glycemic control, weight loss, and improvements in cardiometabolic risk factors — reductions which seemed at ...

Twenty-four weeks of bepirovirsen achieves a functional cure in approximately one-fifth of patients with chronic hepatitis B.

Maternal SARS-CoV-2 infection during pregnancy does not significantly alter early childhood neurodevelopmental outcomes in a meta-analysis.

Patients hospitalized for WNV frequently experience physical and mental long-term sequelae 2 years after hospital discharge.